Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Catabasis Pharmaceuticals, Inc.

NASDAQ: CATBHealthcare / Biotechnology / USA
6.62-0.0700-1.05%Vol 128 0391Y Perf -57.06%
Jan 18th, 2019 16:00
BID6.59 ASK6.62
Open6.68 Previous Close6.69
Pre-Market- After-Trading-
 - -%  - -%
Target Price
40.67 
Analyst Rating
Strong Buy 1.00
Potencial %
514.35 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)47 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
14.95 
Earnings Date
13th Nov 2018

Today's Price Range

6.406.78

 

52wk Range

3.6023.80

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
1 173.08%
3 Months
845.71%
6 Months
782.67%
1 Year
-57.06%
3 Years
21.69%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CATB6.62-0.0700-1.05
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
10.50
Current Ratio
10.80
Long Term Debt to Total Capital
0.04
Total Debt to Equity
0.02
Interest Coverage
-138.80
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-10 050.40
EBITDA Margin
-9 979.20
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.94
PS Ratios
1.41
Price to Cash Flow
-
Price to Free Cash Flow
-2.10
Cash Flow Per Share
-6.19
Price to Tangible Book
0.94
Book Value per Share
5.70
Enterprise Value (in ths.)
-5 162
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
401.75
ROE last 12 Months
-90.10
Return on Assets (5Y Avg)
-80.02
ROA last 12 Months
-74.42
Return on Capital (5Y Avg)
-
ROC last 12 Months
-89.45
Return on invested Capital Q
-13.13
Return on invested Capital Y
-116.15
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.60-0.8050.00
Q02 2018-2.70-2.0025.93
Q01 2018-2.30-2.90-26.09
Q04 2017-3.10-2.4022.58
Q03 2017-3.40-3.108.82
Q02 2017-0.39-0.3217.95
Q01 2017-0.45-0.418.89
Q04 2016-0.49-0.474.08
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.9540.63Positive
12/2018 FY-4.8035.57Positive
3/2019 QR-0.900.00-
12/2019 FY-3.9041.35Positive
Next Report Date-
Estimated EPS Next Report-0.16
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume128 039
Shares Outstanding (in ths.)7 104
Trades Count656
Dollar Volume782 228
Avg. Volume179 078
Avg. Weekly Volume289 502
Avg. Monthly Volume160 952
Avg. Quarterly Volume77 318

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

36%64%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News